Skip to main content
. Author manuscript; available in PMC: 2021 Aug 16.
Published in final edited form as: J Vasc Surg. 2019 May 28;69(6 Suppl):3S–125S.e40. doi: 10.1016/j.jvs.2019.02.016
Recommendations Grade Level of evidence Key references

6.3 Estimate periprocedural risk and life expectancy in patients with CLTI who are candidates for revascularization. 1 (Strong) C (Low) Biancari,63 2007
Schanzer,64 2008
Bradbury,65 2010
Meltzer,66 2013
Simons,67 2016
6.4 Define a CLTI patient as average surgical risk when anticipated periprocedural mortality is <5% and estimated 2-year survival is >50%. 2 (Weak) C (Low)
6.5 Define a CLTI patient as high surgical risk when anticipated periprocedural mortality is ≥5% or estimated 2-year survival is ≤50%. 2 (Weak) C (Low)
HHS Vulnerability Disclosure